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Abstract
Background: The biological effects of cigarette smoke are not fully known. To improve our
understanding of the action of various chemical agents, we investigated the biodistribution of
sodium pertechnetate (Na99mTcO4) in mice exposed to cigarette smoke.
Methods: Fifteen BALB/c male mice were exposed to the smoke of nine whole commercial
cigarettes per day, 3 times/day, for up to 10 days to whole body exposure in a chamber. A control
group of 5 BALB/c male mice was sham-smoked. One day later, the exposed and control groups
of mice received (7.4 MBq/0.3 ml) of Na99mTcO4 before being killed at 30 min. Bones, brain, heart,
intestine, kidney, liver, lungs, muscle, pancreas, spleen, stomach, testis and thyroid were weighed
and these organs and blood radioactivity recorded with a gamma counter. The percentage per gram
of tissue of injected dose (%ID/g) was determined for each organ.
Results: Cigarette smoke significantly decreased (p < 0.05) the %ID/g in red blood cells, bone,
kidney, lung, spleen, stomach, testis and thyroid of the exposed mice.
Conclusion: The toxic effects of cigarette smoke reduced the Na99mTcO4 biodistribution.
Background
Tobacco can be smoked in cigarettes, cigars, pipe, water
pipes, or chewed. It is as an important cash crop, and has
vast economical impact affecting the livelihoods of the
farmers growing it, the companies that manufacture it,
and the healthcare system that deals with the conse-
quences of using it. Cigarette smoking (CS), the most pop-
ular method of smoking tobacco, is one of the most
prevalent social habits practiced worldwide today [1]. The
World Health Organization estimated that almost 1.1 bil-
lion people are smokers. Smoking has been identified as
the leading preventable cause of death and disability in
the world [2,3].
The development of diagnostic tools using radioisotopes
is widely used in almost all hospitals nationwide. In
nuclear medicine practice, physicians set norms for mor-
phological or physiological function for each organ by
diagnosing a large number of patients. For every proce-
dure, there is diagnostic data for a range of normal
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variations familiar to physicians. Nuclear medicine practi-
tioners interpret diseases on the basis of deviations from
these limits [4]. Radioisotopes provide vital information
to help diagnosis and therapy of various medical diseases.
Data on tissue shape, function and localization within the
body are relayed by use of one of various radionuclides,
which can either be a free chemical species or covalently
bound to part of a larger organic or inorganic moiety.
These images are generated by the distribution of radioac-
tive decay of the nuclide [5]. Technetium-99m (99mTc) is
the most frequently used radionuclide in diagnostic
nuclear medicine procedures for a wide variety of diseases
[6]. Various radiochemicals have been labelled with this
nuclide. 99mTc has a half-life of 6 h and emits γ -rays of 140
keV with an abundance of 90%. 99mTc is primarily
obtained from 99Mo/99mTc generator and is eluted as
sodium pertechnetate (Na99mTcO4). In this chemical
form, it can be used to study brain and thyroid [7]. Intra-
venously administered 99mTc-pertechnetate is loosely
bound to plasma proteins and rapidly moves out of the
intravenous compartment. The plasma half-time clear-
ance is ~30 min. Approximately 30% of the administered
dose is excreted within 24 h. The total urinary and faecal
excretion of 99mTc activity is about 50% in 3 days and up
to 70% after 8 days. 99mTc is also trapped by the thyroid
gland and it passes into the small intestine. However in
the brain, the blood-brain barrier prevents
Na99mTcO4from entering brain cells [6,7].
The biodistribution and kinetics of radiochemicals can be
altered by a variety of chemical agents, as is widely known
[8,9]. Without knowing that these chemical agents are
being used, the images can be affected to give poor organ
visualization, possibly necessitating repeating the proce-
dure, and resulting in unnecessary irradiation or even mis-
diagnosis [10]. The effect of CS on the biodistribution of
radiochemicals has not been fully evaluated. The clear-
ance of 99mTc-pentetic acid aerosols is markedly increased
in both sarcoidosis and other inflammatory lung diseases.
However, the limitations of 99mTc-pentetic acids include
the fact that cigarette smoking will also cause increased
clearance [11]. Moreover, the pulmonary uptake of 99mTc-
HMPAO (hexamethylprophylenoaminooxin) induced by
smoking appears to be partially reversible after the cessa-
tion of smoking [12]. We evaluated the biodistribution as
an experimental model to understand the action of vari-
ous chemical agents [13-16]. This study deqals with pos-
sible changes in Na99mTcO4 biodistribution induced by
the effects of CS in an animal model.
Methods
Adult male BALB/c mice were housed, 5 per cage, in a con-
trolled environment room, with light/dark cycle condi-
tions (12 h light/12 h dark, lights on at 6 p.m.), for an
acclimatization period of >3 weeks at an ambient temper-
ature was kept at 25 ± 2°C. The animals had free access to
water and food.
Male BALB/c mice (n = 15), weighting 20–22 g, were
exposed to smoke-air mixture of commercial filtered Vir-
ginia cigarettes, 3 times/day for 1 (CS1d), 5 (CS5d) or 10
(CS10d) days by whole body exposure in an inhalation
chamber. A control group (n = 5), sham-smoke (exposed
to environment air), was also used. This protocol was per-
formed twice with a total of 40 animals, which were
weighed at the end of the experiment.
Each group of mice was placed in the inhalation chamber
(40 cm long, 30 cm wide and 25 cm high), inside an
exhaustion chapel. A cigarette was coupled to a plastic 60
ml syringe so that puffs could be drawn in and subse-
quently expelled into the exposure chamber. We aspirated
one litre of smoke from one cigarette with this syringe (20
puffs of 50 ml) and immediately injected the puff into the
chamber. The 5 animals of each group were maintained in
this smoke-air condition for 6 min (~ 3 %), and the inha-
lation chamber was opened, by removing its cover, and
the smoke evacuated for 1 min by exhaustion of the
chapel. This cigarette exposition was repeated three times
(3 × 6 min) with intervals of 1 min (exhaustion). We
repeated this procedure 3 times per day (morning, lunch
time and afternoon) resulting in a 54 min of CS exposi-
tion of 9 cigarettes. This protocol has been described by us
elsewhere [17] and was an experimental protocol
approved by the Instituto de Biologia Roberto Alcantara
Gomes Animal Research Ethics Committee – UERJ.
Twenty-four hours after exposure, the mice received 0.3
ml of Na99mTcO4 (7.4 MBq) via the ocular plexus, and 30
min later, they were rapidly killed. Heart perfusion was
performed with saline at constant pressure of 25 cm H2O
to clear organs of blood for 5 min. The organs were iso-
lated (bones, brain, heart, intestine, kidney, liver, lungs,
muscle, pancreas, spleen, stomach, testis and thyroid),
their weights determined, and the organs and blood sam-
ple radioactivity of Na99mTcO4 measured by a gamma-
counter NaI (TI) (Cobra Auto-gamma, Packard Instru-
ment Co.; Downers Grove, Illinois, USA). The percentage
per gram of tissue of injected dose (%ID/g) was deter-
mined for each organ. Statistical analyses involved one-
way ANOVA, followed by the Tukey-Kramer Multiple
Comparisons Test, with the significance level being p <
0.05. InStat Graphpad software was used to perform sta-
tistical analysis (GraphPad InStat version 3.00 for Win-
dows 95, GraphPad Software, San Diego Ca, USA).
Results
The effects of CS on the biodistribution of Na99mTcO4 in
isolated organs can first be seen in Table 1, which shows
that CS decreased the %ID/g in red blood cells, bone,BMC Nuclear Medicine 2005, 5:1 http://www.biomedcentral.com/1471-2385/5/1
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kidney, lung, spleen, stomach, testis and thyroid of the
exposed mice. The greatest decrease was at CS10d in kid-
ney (p < 0.001), spleen and testis (p < 0.01). In the stom-
ach, CS exposure changes the %ID/g for CS1d, CS5d and
CS10d (p < 0.05) were comparable with the controls.
Table 2 shows that CS did not change the %ID/g of
Na99mTcO4 significantly in brain, heart, intestine, liver,
muscle and pancreas of exposed animals.
Discussion
Cigarette smoke is a complex mixture of chemicals con-
taining more than 4000 different constituents. Some of
the compounds identified include pyridine alkaloids,
such as nicotine, as well as ammonia, acrolein, phenols,
acetaldehyde, N-nitrosamine; aromatic hydrocarbons
(such as benzopyrene), combustion gases (e.g. carbon
monoxide, nitrogen oxides, and hydrogen cyanide), trace
metals, α -emitter radioactive elements such as polonium,
radium, and thorium. Most of these compounds are pro-
duced by pyrolysis and distillation in the zone immedi-
ately behind the lighted tip of a cigarette, where the
temperature reaches 950°C [18,19]. It has been estimated
that undiluted mainstream smoke contains as much as 30
mg of tar and 5 mg of nicotine in an unfiltered regular tar
cigarette or 0.5 mg tar and 0.05 mg nicotine in a filtered
low-tar cigarette [20].
Radionuclides have been used to investigate diseases
related to smoking [21,22]. In a recent study, Iwado et al.
[23] demonstrated a decrease in the vasomotor response
by PET (positron emission tomography) in the endothe-
lium, in smokers. Moreover, acute CS can diminish cere-
bral blood flow, as was shown with technetium-99m-
labelled ethylcysteine in single-photon emission tomog-
raphy (SPET) on 10 healthy human volunteers [24]. How-
ever, there were no changes in biodistribution in the brain
in our study. However, the blood-brain barrier prevents
Na99mTcO4  from entering normal brain, and the
Table 1: Organs in which CS significantly changed (%ID/g) Na99mTcO4 biodistribution (mean ± SD).
CS effects of Na99mTcO4 biodistribution in mice
Organs Groups
Control Mean ± SD CS1d Mean ± SD CS5d Mean ± SD CS10d Mean ± SD
Red blood cells 3.63 ± 0.24 2.73 ± 0.14* 2.33 ± 0.23** 2.74 ± 0.26*
Bone 0.26 ± 0.07 0.24 ± 0.05 0.15 ± 0.07 0.13 ± 0.05*
Kidney 0.89 ± 0.15 0.80 ± 0.10 0.62 ± 0.09** 0.51 ± 0.05***
Lung 1.72 ± 0.68 1.33 ± 0.28 1.28 ± 0.12 0.86 ± 0.04*
Spleen 0.36 ± 0.12 0.34 ± 0.06 0.22 ± 0.05 0.17 ± 0.05**
Stomach 5.66 ± 1.49 3.53 ± 0.59* 3.24 ± 1.24* 3.37 ± 0.77*
Testis 0.25 ± 0.06 0.19 ± 0.07 0.16 ± 0.03 0.12 ± 0.01**
Thyroid 1.07 ± 0.88 0.80 ± 0.47 0.47 ± 0.38 0.28 ± 0.23*
Statistical significance: (*) p < 0.05, (**) p < 0.01, (***) p < 0.001 when compared with control.
Table 2: Organs in which CS unchanged (%ID/g) Na99mTcO4 biodistribution (mean ± SD).
CS effects of Na99mTcO4 biodistribution in mice
Organs Groups
Control Mean ± SD CS1d Mean ± SD CS5d Mean ± SD CS10d Mean ± SD
Brain 0.11 ± 0.02 0.14 ± 0.04 0.11 ± 0.01 0.10 ± 0.03
Heart 0.53 ± 0.24 0.61 ± 0.17 0.35 ± 0.12 0.48 ± 0.18
Intestine 0.91 ± 0.52 0.47 ± 0.21 0.72 ± 0.18 0.55 ± 0.39
Liver 2.32 ± 1.30 1.60 ± 0.21 2.07 ± 0.89 1.20 ± 0.37
Muscle 0.40 ± 0.35 0.14 ± 0.06 0.24 ± 0.21 0.09 ± 0.03
Pancreas 0.33 ± 0.28 0.16 ± 0.07 0.11 ± 0.03 0.13 ± 0.05BMC Nuclear Medicine 2005, 5:1 http://www.biomedcentral.com/1471-2385/5/1
Page 4 of 5
(page number not for citation purposes)
radioactivity detected may represent a minimal amount of
Na99mTcO4 from blood in brain circulation not cleared
with our perfusion protocol.
Our experimental model showed that CS could affect
%ID/g of Na99mTcO4 distribution in certain organs but
not others. These changes vary according to the time of
exposure; CS10d organs had lower %ID/g when com-
pared to CS5d and CS1d, except for red blood cells, where
there was lower %ID/g in CS5d. In this study, CS affected
Na99mTcO4 %ID/g in red blood cells, bone, kidney, lung,
spleen, stomach, testis and thyroid. It is noteworthy that
some of these organs have also been associated with CS-
induced cancer in humans [25].
Cigarette smoke can interfere with the ability of bone cells
to participate in repairing and remodelling events [26].
This could be one of the mechanisms leading to the devel-
opment of osteoporosis. Pathological analysis of the kid-
ney by Cigremes et al. [27] has shown severe degeneration
of this tissue with advanced hydrophobic degeneration of
kidney tubules in the CS exposed animals.
Kidney radioactivity decreased with CS exposure as a func-
tion of time. There are two different effects of CS; first, less
availability of Na99mTcO4 due to diminished blood flow
to the kidney; and the second is increased permeability or
secretion of Na99mTcO4. Further studies to determine the
levels of Na99mTcO4 in the urine following CS exposure
may conclude whether the decrease in radioactivity is as a
result of one of these above changes.
Significant dependence of alveolar deposition on flow
rate, but not lung function, was found in young non-
symptomatic cigarette smokers and in older non-smokers
with 99mTc-polystyrene particles [28]. This could explain
the significant decrease of Na99mTcO4 %ID/g in mouse
lung at CS10d. Lungs are the main target of cigarette
smoke [17], and a change in biodistribution of
Na99mTcO4 in this experimental design was anticipated.
Sopori et al. [29] have reported results on spleen cells
from animals subjected to heavy doses of cigarette smoke
which show a significant reduction in the natural killer
cell-mediated proteolysis activity and a decreased
response to concanavalin A.
There is a higher incidence of gastric cancer in smokers
than non-smokers and cigarette smoking has also a strong
association with colon cancer [30]. The uptake of
Na99mTcO4 was significantly reduced in the stomach in
our study, although not in the intestine. Technetium99m is
secreted via the stomach mucous and transferred into the
intestine, which leads to an anticipated reduction of its
radioactivity in intestine. Non-significant reduction of
99mTc activity in the intestine is probably due to a great
variability in radioactivity measured in this organ among
animals.
Rajpurkar et al. [31] analysed chronic cigarette smoke on
rat testis, and observed apoptosis, which may be one of
the pathogenic mechanisms responsible for defective
spermatogenesis in these animals, Fisher et al. [32]
showed that chronic smokers have higher thyroxin levels
and a lower thyroid-stimulating hormone level than non-
smokers or former smokers. These results corroborate the
effects on specific organs by CS, which validates this
experimental design as a method to seek alterations of
Na99mTcO4 biodistribution in mice.
The knowledge of radionuclide biodistribution due to
chemical agents will help physicians avoid misinterpret-
ing images and, thus from making incorrect diagnoses.
Such information also helps to prevent or treat possible
adverse reactions to radionuclides [15]. Therefore, devel-
oping models to study the interactions of chemical agents
and radiopharmaceuticals will be of considerable help in
understanding this problem. CS has many compounds
and smoking habits vary in the population; a direct asso-
ciation between the CS effects and the biodistribution of
99mTc has not previously been reported. However, we can-
not comment on how CS changes the biodistribution in
other radionuclides, radiochemicals and radiopharma-
ceuticals. The use of laboratory animals under controlled
experimental conditions provides a good model to test
the hypothesis that CS can change their biodistribution.
When comparing the sensitivity of CS in BALB/c mice to
Na99mTcO4 biodistribution, we cannot exclude the possi-
bility that C57BL6 mice will give better results in the
future. When Na99mTcO4 is used as a powerful diagnostic
tool in nuclear medicine for examining patients to assess
the brain and thyroid, CS can cause alterations in the
readings.
Conclusion
CS induced changes of Na99mTcO4  biodistribution in
exposed BALB/c mice. Na99mTcO4 distribution on kidney,
lung, spleen, testis and thyroid decreased progressively
with CS time exposure from 1 to 10 days. The Na99mTcO4
distribution in stomach and red blood cells was affected
from the first day of CS exposure.
Competing interests
The author(s) declare that they have no competing
interests.
Authors' contributions
SSV – carried out the experimental procedure with the
mouse exposed to CS, performed the statistical analysis
and write the manuscript.BMC Nuclear Medicine 2005, 5:1 http://www.biomedcentral.com/1471-2385/5/1
Page 5 of 5
(page number not for citation purposes)
EACL  – carried out the experimental procedure with
Na99mTcO4 (7.4 MBq) via the ocular plexus.
GFD – determined the radioactivity of the Na99mTcO4 in a
counter NaI (TI)
MB-F  – conceived of the study and participated in its
design and coordination.
LCP – conceived of the study and participated in its design
and coordination.
All authors read and approved the final manuscript.
Acknowledgements
This research was supported by Fundação de Amparo a Pesquisa do Estado 
do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento 
Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de 
Pessoal de Nível Superior (CAPES).
References
1. Rahman I, MacNee W: Oxidant/antioxidant imbalance in smok-
ers and chronic obstructive pulmonary disease. Thorax 1996,
51:348-350.
2. Peto R, Lopez AD, Boreham J, Thun M, Heath CJr: Mortality from
tobacco in developed countries: indirect estimation from
national vital statistics. Lancet 1992, 339:1268-1278.
3. World Health Organization Mortality Statistics, World
Health Statistics Annual 1997–1999  [http://http. //www.who.int/
whosis/mort]
4. Hom RK, Katzenellenbogen JA: Technetium-99m labeled Recep-
tor-specific small-molecule radiopharmaceuticals: recent
developments and encouraging results.  Nucl Med Biol 1997,
24:485-498.
5. Hladik J, Snozzi M, Bachofen R: Incorporation of reaction centers
into submitochondrial particles resulting in light induced
electron transfer. Biochem Biophys Res Commun 1987, 14:170-177.
6. Early PJ, Sodee DB: Principles and practice of nuclear medicine Moseby-
Year Book: London; 1995. 
7. Saha GB, Go RT, MacIntyre WJ: Radiopharmaceucticals for car-
diovascular imaging. Int J Rad Appl Instrum B 1992, 19:1-20.
8. Hesslewood S, Leung E: Drug interactions with
radiopharmaceuticals. Eur J Nucl Med 1994, 21:348-356.
9. Sampson CB: Adverse reactions and drug interactions with
radiopharmaceuticals. Drug Safety 1993, 8:280-294.
10. Lentle BC, Scott JR: Iatrogenic alterations in radionuclide
biodistribution. Semin Nucl Med 1979, 9:131-143.
11. Baughman RP, Fernandez M: Radionuclide imaging in interstitial
lung disease. Curr Opin Pulm Med 1996, 2:376-379.
12. Shih WJ, Lee JK, Coupal J, Lai YL, Grunwald F, Biersack H: Dimin-
ished Tc-99m HMPAO pulmonary uptake in ex-smokers. Clin
Nucl Med 1995, 20:788-791.
13. Capriles PVSZ, Dias APM, Costa TEMM, Oliveira MBN, Faria MVC,
Moura EG, Abreu BAL, Bernardo-Filho M: Effect of eggplant (sola-
num melongena) extract on the in vitro labeling of blood ele-
ments with technetium-99m and on the biodistribution of
sodium pertechnetate in rats. Cell Mol Biol (Noisy-le-grand) 2002,
48:771-776.
14. Feliciano GD, Lima EAC, Pereira MJDS, Oliveira MBS, Moreno SRF,
Mattos DMM, Jales RL, Bernardo-Filho M: Effect of a chayotte
(sechium edule) extract on the labeling of red blood cells and
plasma proteins with technetium-99m: in vitro and in vivo
studies. Cell Mol Biol (Noisy-le-grand) 2002, 48:751-755.
15. Gomes ML, Braga ACS, Mattos DMM, Freitas RS, Boasquevisque E,
Bernardo-Filho M: The effect of mitomycin-C on the biodistri-
bution of 99Tcm-MDP in Balb/c mice. Nucl Med Commun 1998,
19:1177-1179.
16. Gomes ML, Mattos DM, Freitas RS, Dire GF, Lima EA, Souza SM, Ber-
nardo-Filho M: Evaluation of the effect of mitomycin-C on the
bioavailability of technetium-99m-labelled sodium pyro-
phosphate in mice. Cell Mol Biol (Noisy-le-grand) 2002, 48:757-759.
17. Valenca SS, da Hora K, Castro P, Moraes VG, Carvalho L, Porto LC:
Emphysema and metalloelastase expression in mouse lung
induced by cigarette smoke. Toxicol Pathol 2004, 32:351-356.
18. Rodgman A, Smith CJ, Perfetti TA: The composition of cigarette
smoke: a retrospective, with emphasis on polycyclic
components. Hum Exp Toxicol 2000, 19:573-595.
19. Skwarzec B, Ulatowski J, Struminska DI, Borylo A: Inhalation of
210Po and 210Pb from cigarette smoking in Poland. J Environ
Radioact 2001, 57:221-230.
20. Hoffmann D, Hoffmann I: The changing cigarette, 1950–1995. J
Toxicol Environ Health 1997, 50:307-364.
21. Meeder JG, Blanksma PK, van der Wall EE, Anthonio RL, Willemsen
AT, Pruim J, Vaalburg W, Lie KI: Long-term cigarette smoking is
associated with increased myocardial perfusion heterogene-
ity assessed by positron emission tomography. Eur J Nucl Med
1996, 23:1442-1447.
22. Shih WJ, Gruenwald F, Biersack HJ, Berger R, Brandenburg S, Coupal
J, Ryo UY: Tc-99m HMPAO diffuse pulmonary uptake demon-
strated in cigarette smokers. Clin Nucl Med 1991, 16:668-672.
23. Iwado Y, Yoshinaga K, Furuyama H, Ito Y, Noriyasu K, Katoh C, Kuge
Y, Tsukamoto E, Tamaki N: Decreased endothelium-dependent
coronary vasomotion in healthy young smokers. Eur J Nucl Med
Mol Imaging 2002, 29:984-990.
24. Yamamoto Y, Nishiyama Y, Monden T, Satoh K, Ohkawa M: A study
of the acute effect of smoking on cerebral blood flow using
(99m)Tc-ECD SPET. Eur J Nucl Med Mol Imaging 2003, 30:612-614.
25. De Flora S, D'Agostini F, Balansky R, Camoirano A, Bennicelli C, Bag-
nasco M, Cartiglia C, Tampa E, Longobardi MG, Lubet RA, Izzotti A:
Modulation of cigarette smoke-related end-points in muta-
genesis and carcinogenesis. Mutat Res 2003, 523–524:237-252.
26. Liu X, Kohyama T, Kobayashi T, Abe S, Kim HJ, Reed EC, Rennard SI:
Cigarette smoke extract inhibits chemotaxis and collagen
gel contraction mediated by human bone marrow osteopro-
genitor cells and osteoblast-like cells.  Osteoporos Int 2003,
14:235-242.
27. Cigremis Y, Turkoz Y, Akgoz M, Sozmen M: The effects of chronic
exposure to ethanol and cigarette smoke on the level of
reduced glutathione and malondialdehyde in rat kidney. Urol
Res 2004, 32:213-218.
28. Agnew JE, Pavia D, Clarke SW: Factors affecting the alveolar
deposition of 5 microns inhaled particles in healthy subjects.
Clin Phys Physiol Meas 1985, 6:27-36.
29. Sopori ML, Gairola CC, DeLucia AJ, Bryant LR, Cherian S: Immune
responsiveness of monkeys exposed chronically to cigarette
smoke. Clin Immunol Immunopathol 1985, 36:338-344.
30. Shin VY, Wang HY, Liu ES, Koo MW, Cho CH: Differential effects
of cigarette smoke extracts on cell proliferation in gastric
and colon cells. Cancer Invest 2003, 21:200-207.
31. Rajpurkar A, Jiang Y, Dhabuwala CB, Dunbar JC, Li H: Cigarette
smoking induces apoptosis in rat testis. J Environ Pathol Toxicol
Oncol 2002, 21:243-248.
32. Fisher CL, Mannino DM, Herman WH, Frumkin H: Cigarette
smoking and thyroid hormone levels in males. Int J Epidemiol
1997, 26:972-927.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2385/5/1/prepub